Showing results (91-100 of 148) with videos related to
Sort By:
Pageof 15
Cancer Medicine|November 24, 2017
Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithmRaquel E Reinbolt, Stephen Sonis, Cynthia D Timmers, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
Dual inhibition of EGFR and PI3Kinase signaling in EGFR amplified triple negative breast cancer cells induces apoptosis and reduces tumor growthDavid J Wisniewski, Donna Voeller, Yonit A Addissie, et al.Blood Advances|April 12, 2019
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline updateJulia Bohlius, Kari Bohlke, Roberto Castelli, et al.Journal of Cancer Survivorship : Research and Practice|March 11, 2025
Accounting for unmet needs resulting from cancer-related cognitive impairmentDarren Haywood, Alexandre Chan, Raymond J Chan, et al.Journal of the National Cancer Institute. Monographs|May 4, 2023
A review of the impact of energy balance on triple-negative breast cancerNgozi D Akingbesote, Dennis Owusu, Ryan Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2019
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline UpdateJulia Bohlius, Kari Bohlke, Roberto Castelli, et al.Contemporary Clinical Trials Communications|May 30, 2023
Design and methods of a translational, community-based, lifestyle weight management pilot intervention trial in breast cancer survivors with overweight or obesityMarcy L Haynam, Zachary L Chaplow, Victoria R DeScenza, et al.Breast Cancer Research and Treatment|May 13, 2025
Tolerance for chemotherapy-induced peripheral neuropathy among women with metastatic breast cancer: a discrete-choice experimentRotana M Radwan, Anne L R Schuster, Daniel L Hertz, et al.Breast Cancer Research and Treatment|February 6, 2025
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early breast cancer: a discrete choice survey studyErica L Mayer, Mary Lou Smith, Annie Guérin, et al.Journal of Cancer Survivorship : Research and Practice|January 15, 2020
Cognitive problems of breast cancer survivors on proton pump inhibitorsAnnelise A Madison, Alex Woody, Brittney Bailey, et al.Pageof 15